Matthew Roden, Aktis Oncology CEO
Lilly-partnered radiopharma startup Aktis Oncology raises $175M
As other young radiopharmaceutical companies get acquired by drugmakers, Boston-based Aktis Oncology wants to become one of the field’s next hot startups.
On Monday, it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.